<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35192358</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1535-3907</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of proteome research</Title>
          <ISOAbbreviation>J Proteome Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Discovery of Dehydroamino Acid Residues in the Capsid and Matrix Structural Proteins of HIV-1.</ArticleTitle>
        <Pagination>
          <StartPage>993</StartPage>
          <EndPage>1001</EndPage>
          <MedlinePgn>993-1001</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jproteome.1c00867</ELocationID>
        <Abstract>
          <AbstractText>Human immunodeficiency virus type 1 (HIV-1) remains a deadly infectious disease despite existing antiretroviral therapies. A comprehensive understanding of the specific mechanisms of viral infectivity remains elusive and currently limits the development of new and effective therapies. Through in-depth proteomic analysis of HIV-1 virions, we discovered the novel post-translational modification of highly conserved residues within the viral matrix and capsid proteins to the dehydroamino acids, dehydroalanine and dehydrobutyrine. We further confirmed their presence by labeling the reactive alkene, characteristic of dehydroamino acids, with glutathione via Michael addition. Dehydroamino acids are rare, understudied, and have been observed mainly in select bacterial and fungal species. Until now, they have not been observed in HIV proteins. We hypothesize that these residues are important in viral particle maturation and could provide valuable insight into HIV infectivity mechanisms.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Miller</LastName>
            <ForeName>Rachel M</ForeName>
            <Initials>RM</Initials>
            <Identifier Source="ORCID">0000-0003-1461-6386</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Wisconsin, 1101 University Avenue, Madison, Wisconsin 53706, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Knoener</LastName>
            <ForeName>Rachel A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Wisconsin, 1101 University Avenue, Madison, Wisconsin 53706, United States.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>McArdle Laboratory for Cancer Research and Institute for Molecular Virology, University of Wisconsin, Madison, Wisconsin 53705, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benner</LastName>
            <ForeName>Bayleigh E</ForeName>
            <Initials>BE</Initials>
            <AffiliationInfo>
              <Affiliation>McArdle Laboratory for Cancer Research and Institute for Molecular Virology, University of Wisconsin, Madison, Wisconsin 53705, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Frey</LastName>
            <ForeName>Brian L</ForeName>
            <Initials>BL</Initials>
            <Identifier Source="ORCID">0000-0002-0397-7269</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Wisconsin, 1101 University Avenue, Madison, Wisconsin 53706, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scalf</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Wisconsin, 1101 University Avenue, Madison, Wisconsin 53706, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shortreed</LastName>
            <ForeName>Michael R</ForeName>
            <Initials>MR</Initials>
            <Identifier Source="ORCID">0000-0003-4626-0863</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Wisconsin, 1101 University Avenue, Madison, Wisconsin 53706, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sherer</LastName>
            <ForeName>Nathan M</ForeName>
            <Initials>NM</Initials>
            <AffiliationInfo>
              <Affiliation>McArdle Laboratory for Cancer Research and Institute for Molecular Virology, University of Wisconsin, Madison, Wisconsin 53705, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Lloyd M</ForeName>
            <Initials>LM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, University of Wisconsin, 1101 University Avenue, Madison, Wisconsin 53706, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>U54 AI150470</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 GM008505</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R35 GM126914</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 HG002760</GrantID>
            <Acronym>HG</Acronym>
            <Agency>NHGRI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AI110221</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Proteome Res</MedlineTA>
        <NlmUniqueID>101128775</NlmUniqueID>
        <ISSNLinking>1535-3893</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015497" MajorTopicYN="Y">HIV-1</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">HIV-1</Keyword>
        <Keyword MajorTopicYN="Y">bottom-up proteomics</Keyword>
        <Keyword MajorTopicYN="Y">dehydroalanine</Keyword>
        <Keyword MajorTopicYN="Y">dehydrobutyrine</Keyword>
        <Keyword MajorTopicYN="Y">virion</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>17</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35192358</ArticleId>
        <ArticleId IdType="mid">NIHMS1779463</ArticleId>
        <ArticleId IdType="pmc">PMC8976760</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.jproteome.1c00867</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Fiorentini S; Marini E; Caracciolo S; Caruso A, Functions of the HIV-1 matrix protein p17. New Microbiol
2006, 29 (1), 1–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16608119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Proteomics in the investigation of HIV-1 interactions with host proteins. Proteomics Clin Appl
2015, 9 (1–2), 221–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4424045</ArticleId>
            <ArticleId IdType="pubmed">25523935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donnelly MR; Ciborowski P, Proteomics, biomarkers, and HIV-1: A current perspective. Proteomics Clin Appl
2016, 10 (2), 110–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4666820</ArticleId>
            <ArticleId IdType="pubmed">26033875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briggs JA; Simon MN; Gross I; Krausslich HG; Fuller SD; Vogt VM; Johnson MC, The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol
2004, 11 (7), 672–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15208690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hikichi Y; Takeda E; Fujino M; Nakayama E; Matano T; Murakami T, HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events. Virology
2019, 532, 97–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31055063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forshey BM; von Schwedler U; Sundquist WI; Aiken C, Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol
2002, 76 (11), 5667–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC137032</ArticleId>
            <ArticleId IdType="pubmed">11991995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Schwedler UK; Stemmler TL; Klishko VY; Li S; Albertine KH; Davis DR; Sundquist WI, Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J
1998, 17 (6), 1555–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1170503</ArticleId>
            <ArticleId IdType="pubmed">9501077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bukrinskaya A, HIV-1 matrix protein: a mysterious regulator of the viral life cycle. Virus Res
2007, 124 (1–2), 1–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17210199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell EM; Hope TJ, HIV-1 capsid: the multifaceted key player in HIV-1 infection. Nat Rev Microbiol
2015, 13 (8), 471–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4876022</ArticleId>
            <ArticleId IdType="pubmed">26179359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ganser BK; Li S; Klishko VY; Finch JT; Sundquist WI, Assembly and analysis of conical models for the HIV-1 core. Science
1999, 283 (5398), 80–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9872746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pornillos O; Ganser-Pornillos BK; Yeager M, Atomic-level modelling of the HIV capsid. Nature
2011, 469 (7330), 424–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3075868</ArticleId>
            <ArticleId IdType="pubmed">21248851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardone G; Purdy JG; Cheng N; Craven RC; Steven AC, Visualization of a missing link in retrovirus capsid assembly. Nature
2009, 457 (7230), 694–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2721793</ArticleId>
            <ArticleId IdType="pubmed">19194444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S; Hill CP; Sundquist WI; Finch JT, Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature
2000, 407 (6802), 409–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11014200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siodlak D, alpha,beta-Dehydroamino acids in naturally occurring peptides. Amino Acids
2015, 47 (1), 1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4282715</ArticleId>
            <ArticleId IdType="pubmed">25323736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambers KA; Abularrage NS; Hill CJ; Khan IH; Scheck RA, A Chemical Probe for Dehydrobutyrine. Angew Chem Int Ed Engl
2020, 59 (19), 7350–7355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32196905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma S; Caprioli RM; Hill KE; Burk RF, Loss of selenium from selenoproteins: conversion of selenocysteine to dehydroalanine in vitro. J Am Soc Mass Spectrom
2003, 14 (6), 593–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12781460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalker JM; Gunnoo SB; Boutureira O; Gerstberger SC; Fernández-González M; Bernardes GJL; Griffin L; Hailu H; Schofield CJ; Davis BG, Methods for converting cysteine to dehydroalanine on peptides and proteins. Chemical Science
2011, 2 (9), 1666–1676.</Citation>
        </Reference>
        <Reference>
          <Citation>Jones LH, Dehydroamino acid chemical biology: an example of functional group interconversion on proteins. RSC Chemical Biology
2020, 1 (5), 298–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8341704</ArticleId>
            <ArticleId IdType="pubmed">34458767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandrasekar J; Wylder AC; Silverman SK, Phosphoserine Lyase Deoxyribozymes: DNA-Catalyzed Formation of Dehydroalanine Residues in Peptides. J Am Chem Soc
2015, 137 (30), 9575–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4527949</ArticleId>
            <ArticleId IdType="pubmed">26200899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z; Lyons B; Truscott RJ; Schey KL, Human protein aging: modification and crosslinking through dehydroalanine and dehydrobutyrine intermediates. Aging Cell
2014, 13 (2), 226–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4114717</ArticleId>
            <ArticleId IdType="pubmed">24134651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z; Schey KL, Quantification of thioether-linked glutathione modifications in human lens proteins. Exp Eye Res
2018, 175, 83–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6167147</ArticleId>
            <ArticleId IdType="pubmed">29879394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedrich MG; Wang Z; Oakley AJ; Schey KL; Truscott RJW, Hotspots of age-related protein degradation: the importance of neighboring residues for the formation of non-disulfide crosslinks derived from cysteine. Biochem J
2017, 474 (14), 2475–2487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5685506</ArticleId>
            <ArticleId IdType="pubmed">28592682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seebeck FP; Szostak JW, Ribosomal synthesis of dehydroalanine-containing peptides. J Am Chem Soc
2006, 128 (22), 7150–1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2572134</ArticleId>
            <ArticleId IdType="pubmed">16734454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bar-Or R; Rael LT; Bar-Or D, Dehydroalanine derived from cysteine is a common post-translational modification in human serum albumin. Rapid Commun Mass Spectrom
2008, 22 (5), 711–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18265430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gavaret JM; Cahnmann HJ; Nunez J, Thyroid hormone synthesis in thyroglobulin. The mechanism of the coupling reaction. J Biol Chem
1981, 256 (17), 9167–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7021557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gavaret JM; Nunez J; Cahnmann HJ, Formation of dehydroalanine residues during thyroid hormone synthesis in thyroglobulin. J Biol Chem
1980, 255 (11), 5281–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7372636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai KY; Galan SRG; Zeng Y; Zhou TH; He C; Raj R; Riedl J; Liu S; Chooi KP; Garg N; Zeng M; Jones LH; Hutchings GJ; Mohammed S; Nair SK; Chen J; Davis BG; van der Donk WA, LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome. Cell
2021, 184 (10), 2680–2695 e26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8209957</ArticleId>
            <ArticleId IdType="pubmed">33932340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YR; Lees-Miller SP; Tegtmeyer P; Anderson CW, The human DNA-activated protein kinase phosphorylates simian virus 40 T antigen at amino- and carboxy-terminal sites. J Virol
1991, 65 (10), 5131–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC248989</ArticleId>
            <ArticleId IdType="pubmed">1654434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pepinsky RB; Papayannopoulos IA; Campbell S; Vogt VM, Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase. J Virol
1996, 70 (5), 3313–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC190200</ArticleId>
            <ArticleId IdType="pubmed">8627817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perlman DH; Berg EA; O’Connor PB; Costello CE; Hu J, Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids. Proc Natl Acad Sci U S A
2005, 102 (25), 9020–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1157036</ArticleId>
            <ArticleId IdType="pubmed">15951426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solntsev SK; Shortreed MR; Frey BL; Smith LM, Enhanced Global Post-translational Modification Discovery with MetaMorpheus. J Proteome Res
2018, 17 (5), 1844–1851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29578715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q; Shortreed MR; Wenger CD; Frey BL; Schaffer LV; Scalf M; Smith LM, Global Post-Translational Modification Discovery. J Proteome Res
2017, 16 (4), 1383–1390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5387672</ArticleId>
            <ArticleId IdType="pubmed">28248113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davey NE; Satagopam VP; Santiago-Mozos S; Villacorta-Martin C; Bharat TA; Schneider R; Briggs JA, The HIV mutation browser: a resource for human immunodeficiency virus mutagenesis and polymorphism data. PLoS Comput Biol
2014, 10 (12), e1003951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4256008</ArticleId>
            <ArticleId IdType="pubmed">25474213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massiah MA; Starich MR; Paschall C; Summers MF; Christensen AM; Sundquist WI, Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol
1994, 244 (2), 198–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7966331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cannon PM; Matthews S; Clark N; Byles ED; Iourin O; Hockley DJ; Kingsman SM; Kingsman AJ, Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol
1997, 71 (5), 3474–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC191494</ArticleId>
            <ArticleId IdType="pubmed">9094619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freed EO; Orenstein JM; Buckler-White AJ; Martin MA, Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol
1994, 68 (8), 5311–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC236481</ArticleId>
            <ArticleId IdType="pubmed">8035531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Schwedler UK; Stray KM; Garrus JE; Sundquist WI, Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol
2003, 77 (9), 5439–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC153941</ArticleId>
            <ArticleId IdType="pubmed">12692245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dochi T; Nakano T; Inoue M; Takamune N; Shoji S; Sano K; Misumi S, Phosphorylation of human immunodeficiency virus type 1 capsid protein at serine 16, required for peptidyl-prolyl isomerase-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2. J Gen Virol
2014, 95 (Pt 5), 1156–1166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24509437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rihn SJ; Wilson SJ; Loman NJ; Alim M; Bakker SE; Bhella D; Gifford RJ; Rixon FJ; Bieniasz PD, Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog
2013, 9 (6), e1003461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3688543</ArticleId>
            <ArticleId IdType="pubmed">23818857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>del Alamo M; Neira JL; Mateu MG, Thermodynamic dissection of a low affinity protein-protein interface involved in human immunodeficiency virus assembly. J Biol Chem
2003, 278 (30), 27923–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12761222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bon Homme M; Carter C; Scarlata S, The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes. Biophys J
2005, 88 (3), 2078–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1305260</ArticleId>
            <ArticleId IdType="pubmed">15626706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovaleski BJ; Kennedy R; Khorchid A; Kleiman L; Matsuo H; Musier-Forsyth K, Critical role of helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase. J Biol Chem
2007, 282 (44), 32274–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17724017</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
